Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes

Journal of the National Medical Association

Volumn 98, Issue 11, 2006, Pages 1746-1750

  Coskun, Selçuk ^a   Atalar, Enver ^a,c   Ozturk, Ercan ^a   Yavuz, Bunyamin ^b   Özer, Necla ^a   Goker, Hakan ^a   Övünç, Kenan ^a   Aksöyek, Serdar ^a   Kes, Sirri ^a   Sivri, Bulent ^a   Kirazli, Serafettin ^a   Özmen, Ferhan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Kecioren Hospital Ankara   (Turkey)

^c NONE   (Turkey)

Author keywords

Acute coronary syndrome; Coronary artery disease; Non ST segment elevation myocardial infarction; Osteopontin; Unstable angina

Indexed keywords

OSTEOPONTIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CORONARY STENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OSTEOPONTIN; PROGNOSIS; SYNDROME;

EID: 33845372542     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
2. Davies MJ. Stability and instability: the two faces of coronary atherosclerosis. Circulation. 1996;94:2013-2020.
3. Lendon CL, Davies MJ, Born GV, et al. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis. 1991;87:87-90.
4. Serneri GG, Abbate R, Gori AM, et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation. 1992;86:790-797.
5. Moreno PR, Falk E, Palacious IF, et al. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation. 1994;90:775-778.
6. Buja LM, Willerson TJ. Role of inflammation in coronary plaque disruption. Circulation. 1994;89:503-505.
7. Van der wal AC, Becker AE, Van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
8. Atalar E, Aytemir K, Haznedaroglu I, et al. Increased plasma levels of soluble selectins in patients with unstable angina. Int J Cardiol. 2001;78:69-73.
9. Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Mini review. Matrix Biol. 2000;19:615-622.
10. Koguchi Y, Kawakami K, Uezu K, et al. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am J Respir Crit Care Med. 2003;167:1355-1359.
11. Nasu K, Ishida T, Setoguchi M, et al. Expression of wild-type and mutated rabbit osteopontin in Escherichia coli and their effects on adhesion and migration of P388D1 cells. Biochem J. 1995;07:257-265.
12. Tyson KL, Reynolds JL, McNair R, et al. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol. 2003;23:489-494.
13. O'Brien ER, Garvin MR, Stewart DK, et al. Osteopontin is synthesized by macrophage, smooth muscle cell, and endothelial cells in primary and restenotic human atherosclerotic plaques. Arterioscler Thromb. 1994;14:1648-1656.
14. Fitzpatrick LA, Severson A, Edwards WD, et al. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest. 1994;93:1597-1604.
15. Takemoto M, Yokote K, Nishumara M, et al. Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherosclerosis. Arteroscler Thromb Vasc Biol. 2000;20:624-628.
16. Dhore CR, Cleutjens JP, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001;21:1998-2003.
17. Tamura A, Shingai M, Aso N, et al. Osteopontin is released from the heart in to the coronary circulation in patients with a previous anterior wall myocardial infarction. Circ J. 2003;67:742-744.
18. Ohmoria R, Momiyama Y, Taniguchi H, et al. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis. 2003;170:333-337.
19. Suezawa C, Kusachi S, Murakami T, et al. Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: Correlation with left-ventricular volume and fuction. J Lab Clin Med. 2005;145:33-40.
20. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 Guideline Update for the Management of Patients with Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction. 2002: summary article. Circulation. 2002;106:1893-1900.
21. Kon S, Yokosaki Y, Maeda M, et al. Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences. J Cell Biochem. 2002;84(2):420-432.